23 Apr, 2013Virtual Drug Discovery: the Information Age is Transforming Research


In part one of four, published on Pharmaphorum last month, Dr Kevin Lustig and Dr Maria Thompson of Assay Depot discussed the changing…

Read More

04 Apr, 20136 Ways Near Sourcing Helps the Life Sciences


Outsourcing is frequently associated with overseas work, however it encompasses all work that you are sending outside the company,including work to those CRO’s…

Read More

28 Mar, 2013Contract Research Outsourced in Minutes


The ultimate goal of Assay Depot is to connect scientists with service providers. There are thousands of Contract Research Organizations (CROs) that provide…

Read More

19 Mar, 2013Pharmaceutical outsourcing: strategic versus tactical partnerships


Successful pharmaceutical outsourcing requires realistic and well-defined expectations, a strong vendor-client relationship, and continued client involvement in the outsourced project as it evolves….

Read More

12 Mar, 2013Outsourcing with realistic expectations


From pharmaceuticals to financial services, the motives that drive outsourcing are fundamental. Top among them are perceived cost savings, improved outcome, and the…

Read More

05 Mar, 2013Pharmaceutical Outsourcing: Where is the Work Going?


Last week we blogged about the growing trend in pharmaceutical outsourcing. When people hear the word “outsourcing”, many assume that means that work…

Read More

27 Feb, 2013Outsourcing Offers Flexibility and Potential Cost Savings


By some estimates, the pharmaceutical outsourcing market could grow to $65 billion by 2018, fueled by a compound annual growth rate of nearly…

Read More

26 Feb, 2013Research Exchanges: A New Engine


I’m sure it comes as no surprise to anyone reading this article that we have a problem in drug development. Pharmaceutical companies are having to face up…

Read More

19 Feb, 2013Contract Research Organizations: Has the Future Arrived?


It’s not hard to find articles, blog posts, or market reports these days that state contract research organizations, and outsourcing in general, is the future for the pharmaceutical industry. What I haven’t seen, until today, is anyone claiming that future has arrived and become the present. An article published by Industrial Info Resources titled “Big Pharma Keeps CMOs and CROs on Speed Dial, an Industrial Info News Alert”[1] seems to do just that. Their opening line of the article’s abstract states, “Outsourcing can no longer be regarded as the wave of the future. At least in the case of the Pharmaceutical-Biotech Industry …”, but I’m not sure we are there just yet.

Read More

29 Nov, 2012Pharmaceutical Outsourcing: A glimpse into the Future


Assay Depot’s Kevin Lustig and Chris Petersen were recently asked to co-author a book chapter on the future of Pharmaceutical Outsourcing. It is gratifying to see that once again Assay Depot is being recognized as a thought leader and game changer in the field of drug development. If you have been following our blog you will know that Kevin was recognized as one of The 100 most inspiring people in Drug Development by PharmaVoice, and that Assay Depot was selected as one of the 2012 finalists in the Red Herring Top 100, recognizing the most innovative global companies.

Read More